• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成年肥厚型心肌病患者的心肌桥

Myocardial bridging in adult patients with hypertrophic cardiomyopathy.

作者信息

Sorajja Paul, Ommen Steve R, Nishimura Rick A, Gersh Bernard J, Tajik A Jamil, Holmes David R

机构信息

Division of Cardiovascular Disease and Internal Medicine, Mayo Clinic and Foundation, 200 SW First Street, Rochester, MN 55905, USA.

出版信息

J Am Coll Cardiol. 2003 Sep 3;42(5):889-94. doi: 10.1016/s0735-1097(03)00854-4.

DOI:10.1016/s0735-1097(03)00854-4
PMID:12957438
Abstract

OBJECTIVES

This investigation examined the risk of sudden cardiac death and other mortality in adult patients with hypertrophic cardiomyopathy (HCM) who have myocardial bridging diagnosed at coronary angiography.

BACKGROUND

Several reports have associated myocardial bridging with an adverse prognosis in pediatric HCM patients, but the prognosis of myocardial bridging in adult patients with HCM is unknown.

METHODS

The coronary angiograms of 425 patients with HCM (mean age 60 +/- 15 years [range 18 to 89 years]) at the Mayo Clinic were examined for the presence of myocardial bridging. Clinical follow-up was conducted to assess mortality. Survival of patients with bridging was compared with HCM patients who also underwent angiography but who did not have evidence of bridging.

RESULTS

A total of 64 patients (15%) had myocardial bridging. The mean follow-up for the entire study was 6.8 +/- 5.4 years. There was no difference in survival free of all-cause mortality (5-year estimate, bridging vs. no bridging, 91% vs. 85%; p = 0.42), all cardiac death (93% vs. 89%; p = 0.60), and sudden cardiac death (95% vs. 97%; p = 0.72). Univariate and multivariate proportional hazards models also did not identify the presence of bridging or specific characteristics of the degree or extent of bridging with a poor outcome.

CONCLUSIONS

This study observed no increased risk of death, including sudden cardiac death, among adult patients with HCM who had myocardial bridging diagnosed at coronary angiography.

摘要

目的

本研究调查了在冠状动脉造影时被诊断为心肌桥的肥厚型心肌病(HCM)成年患者发生心源性猝死及其他死亡的风险。

背景

多项报告表明心肌桥与小儿HCM患者的不良预后相关,但成年HCM患者中心肌桥的预后尚不清楚。

方法

对梅奥诊所425例HCM患者(平均年龄60±15岁[范围18至89岁])的冠状动脉造影进行检查,以确定是否存在心肌桥。进行临床随访以评估死亡率。将有心肌桥的患者生存率与同样接受了血管造影但无心肌桥证据的HCM患者进行比较。

结果

共有64例患者(15%)存在心肌桥。整个研究的平均随访时间为6.8±5.4年。在全因死亡率(5年估计,有心肌桥与无心肌桥分别为91%对85%;p = 0.42)、所有心源性死亡(93%对89%;p = 0.60)和心源性猝死(95%对97%;p = 0.72)方面无差异。单因素和多因素比例风险模型也未发现心肌桥的存在或心肌桥程度或范围的特定特征与不良结局相关。

结论

本研究观察到,在冠状动脉造影时被诊断为心肌桥的成年HCM患者中,包括心源性猝死在内的死亡风险并未增加。

相似文献

1
Myocardial bridging in adult patients with hypertrophic cardiomyopathy.成年肥厚型心肌病患者的心肌桥
J Am Coll Cardiol. 2003 Sep 3;42(5):889-94. doi: 10.1016/s0735-1097(03)00854-4.
2
Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death.肥厚型心肌病患儿的心肌桥——猝死的一个危险因素。
N Engl J Med. 1998 Oct 22;339(17):1201-9. doi: 10.1056/NEJM199810223391704.
3
Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease.患有心外膜冠状动脉疾病的肥厚型心肌病患者的不良预后。
Circulation. 2003 Nov 11;108(19):2342-8. doi: 10.1161/01.CIR.0000097110.55312.BF. Epub 2003 Oct 27.
4
Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.心肌桥是肥厚型心肌病表型的常见组成部分,与心源性猝死缺乏系统性关联。
Eur Heart J. 2009 Jul;30(13):1627-34. doi: 10.1093/eurheartj/ehp121. Epub 2009 Apr 30.
5
Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease.心肌桥并不能预测肥厚型心肌病患儿的猝死,但与更严重的心脏疾病相关。
J Am Coll Cardiol. 2000 Dec;36(7):2270-8. doi: 10.1016/s0735-1097(00)00987-6.
6
Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.泰国成年肥厚型心肌病患者的死亡模式和临床结局。
BMC Cardiovasc Disord. 2019 Jan 3;19(1):1. doi: 10.1186/s12872-018-0984-0.
7
Relationship between myocardial bridging and fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy: the HCM-MB study.肥厚型心肌病患者心肌桥与致命性室性心律失常的关系:HCM-MB 研究。
Herz. 2023 Oct;48(5):399-407. doi: 10.1007/s00059-023-05171-9. Epub 2023 Apr 20.
8
Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.肥厚型心肌病中的非持续性室性心动过速:年轻患者猝死风险的独立标志物。
J Am Coll Cardiol. 2003 Sep 3;42(5):873-9. doi: 10.1016/s0735-1097(03)00827-1.
9
Myocardial bridging as a common phenotype of hypertrophic cardiomyopathy has no effect on prognosis.心肌桥作为肥厚型心肌病的一种常见表型,对预后没有影响。
Am J Med Sci. 2014 Jun;347(6):429-33. doi: 10.1097/MAJ.0000000000000194.
10
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.植入式心律转复除颤器预防肥厚型心肌病儿童和青少年心源性猝死。
J Am Coll Cardiol. 2013 Apr 9;61(14):1527-35. doi: 10.1016/j.jacc.2013.01.037.

引用本文的文献

1
Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.《2024年墨西哥肥厚型心肌病诊断与治疗指南》
Arch Cardiol Mex. 2024;94(Supl 4):1-75. doi: 10.24875/ACM.M25000098.
2
Coronary Myocardial Bridge Updates: Anatomy, Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment Options.冠状动脉心肌桥的最新进展:解剖、病理生理学、临床表现、诊断及治疗选择
Tex Heart Inst J. 2025 Jan 30;52(1):e238300. doi: 10.14503/THIJ-23-8300. eCollection 2025 Jan-Jun.
3
Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024.
肥厚型心肌病诊断与治疗指南 - 2024
Arq Bras Cardiol. 2024 Jul 26;121(7):e202400415. doi: 10.36660/abc.20240415.
4
Successful management of ischaemic symptoms in a patient with asymmetric septal hypertrophy: a grand round case report.非对称性室间隔肥厚患者缺血症状的成功管理:一例临床病例讨论报告
Eur Heart J Case Rep. 2024 Apr 25;8(5):ytae213. doi: 10.1093/ehjcr/ytae213. eCollection 2024 May.
5
A Comprehensive Review of Myocardial Bridging: Exploring Diagnostic and Treatment Modalities.心肌桥的全面综述:探索诊断与治疗方式
Cureus. 2023 Aug 8;15(8):e43132. doi: 10.7759/cureus.43132. eCollection 2023 Aug.
6
Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy.肥厚型心肌病中心肌缺血的机制及预后影响
Int J Cardiovasc Imaging. 2023 Oct;39(10):1979-1996. doi: 10.1007/s10554-023-02894-y. Epub 2023 Jun 26.
7
Coronary Artery Anomalies: A Short Case Series and Current Review.冠状动脉异常:一个简短的病例系列及当前综述
Cureus. 2023 May 8;15(5):e38732. doi: 10.7759/cureus.38732. eCollection 2023 May.
8
Effects of bariatric surgery on cardiovascular-related acute care use in patients with hypertrophic cardiomyopathy.减重手术对肥厚型心肌病患者心血管相关急症治疗的影响。
ESC Heart Fail. 2023 Aug;10(4):2438-2446. doi: 10.1002/ehf2.14414. Epub 2023 May 31.
9
Myocardial bridging in adult with hypertrophic cardiomyopathy: Imaging findings with coronary computed tomography angiography.成人肥厚型心肌病合并心肌桥:冠状动脉计算机断层扫描血管造影的影像学表现
Radiol Case Rep. 2022 Sep 29;17(12):4627-4631. doi: 10.1016/j.radcr.2022.08.095. eCollection 2022 Dec.
10
Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者伴非阻塞性冠状动脉的急性冠状动脉综合征(ACS-NOCA)。
BMC Cardiovasc Disord. 2021 Nov 19;21(1):556. doi: 10.1186/s12872-021-02373-z.